Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03081546 · ClinicalTrials.gov registry record
Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 41
- Enrollment target
NCT03081546: Completed study, sponsored by University of Colorado, Denver.
NCT03081546 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03081546 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
This study plans to assess the effectiveness of performance-based functional assessments (PBFAs) and cognitive assessments in diagnosing Alzheimer's disease in Hispanic/Latino populations. The information from this study will be analyzed with data from the Rocky Mountain Alzheimer's Disease Center Bio-AD study (NCT02612376).
Primary Outcome
Measure independent functioning in everyday life for controls and individuals with MCI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2017-05-04 |
| Est. Completion | 2018-09-01 |
What the finished NCT03081546 record still lists
NCT03081546 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03081546 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03081546 about?
NCT03081546 is a clinical study titled "Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease". This study plans to assess the effectiveness of performance-based functional assessments (PBFAs) and cognitive assessments in diagnosing Alzheimer's disease in Hispanic/Latino populations. The information from this study will be analyzed with data from the Rocky Mountain Alzheimer's Disease Center B...
What is the current status of trial NCT03081546?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2017-05-04. Estimated completion is 2018-09-01.
Who is sponsoring clinical trial NCT03081546?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI